GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Collegium Pharmaceutical
Collegium Pharmaceutical specializes in pain medications with abuse-resistant technology. Its stock price reflects the demand for safer opioids amid the opioid crisis in the US, as well as the risks associated with regulation and litigation in this area.
Share prices of companies in the market segment - Narco farm
Collegium Pharmaceutical specializes in painkillers with abuse-resistant technology. We classify it as part of the Narcofarm sector, and the chart below reflects the dynamics of the entire pain management industry.
Broad Market Index - GURU.Markets
Collegium Pharmaceutical is a pharmaceutical company specializing in the development and sale of pain medications developed using abuse-deterrent technology. It is a component of the GURU.Markets index. The chart below represents the market. See how Collegium shares compare to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
COLL - Daily change in the company's share price Collegium Pharmaceutical
Daily fluctuations in Collegium Pharmaceutical, a pain medication company, reflect regulatory and legal risks in the sector. Change_co shows sensitivity to sales and patent disputes. This metric is key to pharmaceutical sector analysis on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Narco farm
Collegium Pharmaceutical, Inc. is a pharmaceutical company. This chart highlights the sector's high volatility. Comparing it to COLL, which focuses on pain medications, helps understand its unique regulatory risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
Collegium is a pharmaceutical company specializing in pain medications. The pharmaceutical sector operating in this area is volatile and under close regulatory scrutiny. The chart below reflects the average fluctuations in this niche, helping to assess Collegium's risks and potential.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Collegium Pharmaceutical
Collegium is a pharmaceutical company specializing in abuse-resistant painkillers. Its year-over-year performance reflects both the demand for its products and the complex legal and regulatory risks associated with this sensitive area.
Annual dynamics of market capitalization of the market segment - Narco farm
Collegium Pharmaceutical, Inc. is a pharmaceutical company focused on pain treatment. It develops abuse-resistant drugs. This chart shows how its unique technology, competition, and the complex regulatory environment in the pain relief market impact its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Collegium, which specializes in pain medications, operates in a complex and highly regulated niche. Its stock price is driven not by the economy, but by sales volume, generic competition, and legal risks. The chart tells the story of how the company is struggling to grow amid the opioid crisis.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Collegium Pharmaceutical
The value of Collegium, a pharmaceutical company focused on painkillers, depends on its product cycle. The monthly fluctuations on the chart reflect the sales data of its drugs and the company's ability to navigate the strict regulations and litigation risks associated with the opioid market.
Monthly dynamics of market capitalization of the market segment - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of abuse-resistant pain medications. The company's business is at the center of the complex opioid crisis. The pharmaceutical sector dynamics chart provides a general backdrop, but for Collegium, regulatory decisions and the ability of doctors and patients to accept its safer alternatives are key.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of pharmaceutical companies operating in a complex field like painkillers often move on regulatory and sales news. The chart below shows the general trends. How does Collegium Pharmaceutical's story compare to the general backdrop?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Collegium Pharmaceutical
Collegium Pharmaceutical, a company focused on abuse-resistant pain medications, whose weekly stock price reflects competition in the painkiller market and regulatory trends. Sales data and patent disputes drive short-term fluctuations.
Weekly dynamics of market capitalization of the market segment - Narco farm
Collegium, like other specialty pharmaceutical companies, is part of a volatile sector. The chart compares its performance with the industry as a whole to see how much of its weekly fluctuations are driven by general pharma regulatory news and how much by specific sales data for its painkillers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Collegium Pharmaceutical specializes in abuse-resistant pain medications. Its business is under regulatory scrutiny. This chart shows how Collegium shares move based on sales and litigation news, rather than general market trends.
Market capitalization of the company, segment and market as a whole
COLL - Market capitalization of the company Collegium Pharmaceutical
The Collegium Pharmaceutical chart is a financial roadmap for the fight against pain and opioid addiction. The company's market cap reflects the demand for its painkillers, which feature technology that makes them difficult to misuse. Its dynamics are a barometer of the complex situation in the opioid market, where the need for pain treatment clashes with the need for control.
COLL - Share of the company's market capitalization Collegium Pharmaceutical within the market segment - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-resistant products. Its market share reflects its position in this socially significant niche. The chart below shows how the market values its pain medication portfolio.
Market capitalization of the market segment - Narco farm
Collegium Pharmaceutical specializes in pain medications designed to reduce the risk of abuse. The chart below shows the overall market capitalization of the entire pharmaceutical industry. Its dynamics provide the backdrop against which the company is addressing the pressing issue of the opioid crisis.
Market capitalization of all companies included in a broad market index - GURU.Markets
Collegium Pharmaceutical specializes in developing abuse-resistant pain medications. Its market capitalization chart tells the story of balancing pain relief and safety in the midst of the opioid crisis. It shows how the company is carving out its niche in this challenging market.
Book value capitalization of the company, segment and market as a whole
COLL - Book value capitalization of the company Collegium Pharmaceutical
Collegium Pharmaceutical's book value is its equity and production assets. The chart below shows the material and financial basis for developing and selling pain medications. Its dynamics reflect investments in R&D and product lifecycle management.
COLL - Share of the company's book capitalization Collegium Pharmaceutical within the market segment - Narco farm
Collegium Pharmaceutical specializes in abuse-resistant pain medications. Manufacturing such complex drugs requires specialized facilities. The asset share chart shows how the company is investing in its own physical facilities to ensure quality and safety.
Market segment balance sheet capitalization - Narco farm
Collegium Pharmaceutical specializes in abuse-resistant pain medications. Its business requires investment in R&D, as well as marketing and distribution. The chart shows how its book value reflects not only its intangible patents but also its commercial infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Collegium Pharmaceutical's assets comprise a portfolio of pain treatment drugs. The company's book value reflects its rights to patented technologies that make opioid analgesics more abuse-resistant. This intellectual and material capital is aimed at safer management of severe pain.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Collegium Pharmaceutical
Collegium Pharmaceutical specializes in abuse-resistant pain medications. Its book value reflects its R&D and manufacturing assets, while its market capitalization reflects its proprietary technologies and ability to market its products in a highly regulated environment and the opioid crisis.
Market to book capitalization ratio in a market segment - Narco farm
Collegium Pharmaceutical specializes in pain medications, focusing on abuse-prevention technologies. The company's value lies in its patents. The chart shows how the market values its products and its ability to compete in the complex pain relief market relative to its tangible assets.
Market to book capitalization ratio for the market as a whole
Collegium Pharmaceutical specializes in developing abuse-resistant pain treatments. The company's value lies in its patented technologies and sales of existing products. The chart shows how the market values this pharmaceutical company, which is solving a complex social and medical problem.
Debts of the company, segment and market as a whole
COLL - Company debts Collegium Pharmaceutical
Collegium Pharmaceutical, a pain medication specialist, uses debt to manage its product portfolio. This chart may reflect funding used to acquire rights to other drugs or for marketing efforts to promote its abuse-resistant products.
Market segment debts - Narco farm
Collegium Pharmaceutical specializes in developing abuse-resistant pain treatments. In the pharmaceutical sector, especially in such a sensitive area, debt can fund marketing, research, and patent protection. The chart shows how the company manages its finances in a highly regulated and competitive environment.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Collegium Pharmaceutical
Collegium Pharmaceutical specializes in pain medications, focusing on abuse-deterrent technologies. This market is under close regulatory scrutiny. This chart shows how the company manages its finances. Debt levels may indicate funding for marketing or acquisitions to expand the product portfolio.
Market segment debt to market segment book capitalization - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-resistant products. This market is under close regulatory scrutiny. The chart shows the overall debt burden in the pharmaceutical industry, which helps assess how the company manages regulatory risks and commercialization.
Debt to book value of all companies in the market
Collegium Pharmaceutical operates in the painkiller market, which is under close scrutiny. This chart shows the overall debt burden of the economy. It helps assess how insulated the company's business is from economic cycles, as demand for its products is driven by medical needs, not by patients' financial circumstances.
P/E of the company, segment and market as a whole
P/E - Collegium Pharmaceutical
Collegium Pharmaceutical specializes in developing abuse-resistant pain medications. This chart reflects its position in the challenging pain relief market. Its performance depends on its product sales volumes, patent protection, and ability to compete in an environment of strict regulation and public attention to the opioid crisis.
P/E of the market segment - Narco farm
Collegium Pharmaceutical operates in the specialty pharmaceuticals sector. This chart shows the average P/E ratio for this industry. Comparing a company's P/E to this ratio helps understand whether the market views its abuse-resistant pain medications as more promising and competitively insulated than those of other pharmaceutical companies.
P/E of the market as a whole
Collegium Pharmaceutical specializes in developing pain treatments with abuse-resistant technologies. The company operates in a complex market under intense regulatory scrutiny. This chart reflects sentiment in the pharmaceutical sector. It helps understand how the market views the company's ability to grow amid the opioid crisis and patent competition.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Collegium Pharmaceutical
Collegium Pharmaceutical specializes in the development and marketing of pain medications, focusing on abuse-resistant products. This chart reflects market expectations for safer painkillers. Future profits depend on the patent protection of its products and regulatory policies regarding opioids.
%20P%2FE%20Collegium%20Pharmaceutical&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Collegium-Pharmaceutical&v=1772615999194 "Chart of the company's future (projected) P/E Collegium Pharmaceutical")
Future (projected) P/E of the market segment - Narco farm
Collegium Pharmaceutical specializes in developing and marketing abuse-resistant painkillers. This chart shows how the market views its future profitability amid the opioid crisis. It reflects investor sentiment on its ability to navigate the complex regulatory environment and the demand for safer painkillers.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772615999212 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on reducing the risk of abuse. Demand for their products depends on physician prescriptions and the fight against the opioid crisis. The overall economic backdrop, as illustrated by this chart, influences healthcare budgets and pharmaceutical priorities.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772615999313 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Collegium Pharmaceutical
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-resistant products. The company's financial performance depends on sales volumes of its key drugs and competition in the pain relief market. This chart shows how patents and marketing efforts impact market share and profitability.
Profit of companies in the market segment - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of pain medications with abuse-deterrent properties. This chart, showing overall profitability in the pharmaceutical sector, reflects the response to the opioid crisis. The success of Collegium's products directly impacts changes in pain medication prescribing standards and the profitability of this segment.
Overall market profit
Collegium Pharmaceutical specializes in developing pain medications with technologies that reduce misuse. The company operates in a complex and highly regulated market, striving to offer safer alternatives to traditional opioids. Its success depends on regulatory decisions and the acceptance of its products by physicians.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Collegium Pharmaceutical
Collegium Pharmaceutical specializes in the development and commercialization of abuse-resistant pain medications. Future profit projections in this chart depend on sales of its flagship products. Analysts assess physician prescription trends and the competitive landscape in the challenging pain medication market.
%20profit%20of%20the%20company%20Collegium%20Pharmaceutical&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Collegium-Pharmaceutical&v=1772615999474 "Graph of future (projected) profit of the company Collegium Pharmaceutical")
Future (predicted) profit of companies in the market segment - Narco farm
Collegium Pharmaceutical focuses on developing and commercializing pain medications with abuse-deterrent properties. This chart reflects revenue forecasts for the entire pain medication sector. It allows one to assess how the company's products aimed at combating the opioid crisis compare to overall trends in this complex field.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772615999502 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Collegium Pharmaceutical specializes in developing abuse-resistant pain medications. Demand for these products is driven by medical necessity and the regulatory environment. General economic conditions, as reflected in this chart, have a lesser impact on the company but can affect the ability of patients and insurers to pay.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772615999586 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Collegium Pharmaceutical
Collegium Pharmaceutical specializes in developing and selling abuse-resistant painkillers. This metric, which correlates market capitalization with sales, reflects its efforts to address the opioid crisis. It shows how investors view its product portfolio and its ability to fill a niche in the painkiller market.
P/S market segment - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of pain medications with abuse-deterrent properties. The company strives to provide safer pain relief options. This chart reflects how the market values pharmaceutical revenue, which helps understand how investors value Collegium's products in the context of the opioid crisis.
P/S of the market as a whole
Collegium Pharmaceutical is a pharmaceutical company specializing in the development and commercialization of pain medications, with a focus on abuse-resistant products. This chart provides an overview of how the market perceives companies operating in the complex and regulated field of pain medications, given the overall market environment.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Collegium Pharmaceutical
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-resistant products. This chart shows how investors value the company based on its projected future sales. It reflects expectations of demand for safer painkillers amid the opioid crisis.
%20P%2FS%20Collegium%20Pharmaceutical&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Collegium-Pharmaceutical&v=1772615999795 "The graph of the company's future (projected) P/S Collegium Pharmaceutical")
Future (projected) P/S of the market segment - Narco farm
Collegium Pharmaceutical is a pharmaceutical company specializing in the development and commercialization of pain medications, with a focus on abuse-resistant products. This chart compares investor expectations for its future revenue with the sector. The estimate reflects investor opinions on the sales of its flagship products and the overall pain relief market.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772615999810 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Collegium Pharmaceutical specializes in the development and marketing of pain medications, with a focus on abuse-resistant products. The company's success depends on addressing the opioid crisis and the demand for safer analgesics. This graph of investor expectations reflects their view of the pharmaceutical market and its ability to address pressing social issues.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772615999900 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Collegium Pharmaceutical
Collegium Pharmaceutical's revenue is generated in the highly regulated painkiller market. The company specializes in producing opioid medications with technology that makes them less prone to misuse. The growth in this chart reflects its market share in chronic pain treatments and the demand for safer prescription medications.
Sales of companies in the market segment - Narco farm
Collegium Pharmaceutical is a specialty pharmaceutical company developing and commercializing pain medications. The company focuses on creating abuse-resistant products. This chart represents the total revenue of the entire pain medication market, highlighting the important niche of responsible pain management in which Collegium operates.
Overall market sales
Collegium Pharmaceutical, Inc. specializes in pain medications. Demand for its products is driven by medical needs, not economic cycles. However, the overall economic situation, reflected in this chart, influences insurance coverage and patient affordability, which can impact the availability and pricing of specialized medications.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Collegium Pharmaceutical
Collegium Pharmaceutical specializes in the development and marketing of pain medications, with a focus on reducing the risk of abuse. Its success depends on sales of its flagship products and competition in the painkiller market. This chart shows analyst expectations for the chronic pain medication market and the company's market share.
%20sales%20of%20the%20company%20Collegium%20Pharmaceutical&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Collegium-Pharmaceutical&v=1772616000080 "Schedule of future (projected) sales of the company Collegium Pharmaceutical")
Future (projected) sales of companies in the market segment - Narco farm
Collegium Pharmaceutical is a pharmaceutical company specializing in pain medications. This chart details projected sales of their key products developed with abuse-resistant technology. This allows analysts to assess the market potential of these drugs amid the opioid crisis.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772616000104 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
Healthcare spending forecasts, particularly in the area of pain management, which are part of the overall expectations in this chart, are important for Collegium Pharmaceutical. The company focuses on abuse-resistant pain medications. Demand is driven by patient needs and regulatory policies to combat the opioid crisis.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772616000134 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Collegium Pharmaceutical
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-deterrent technologies. This chart shows profitability in a complex pharmaceutical segment. Profitability depends on prescription volumes and successful competition from other opioid and non-opioid analgesics.
Market segment marginality - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-resistant products. The company's profitability depends on sales of its pain medications. This chart shows the average profitability in the pharmaceutical industry. It helps assess how successfully Collegium operates in a complex and highly regulated niche.
Market marginality as a whole
Collegium Pharmaceutical develops and commercializes pain medications. Demand for its products depends on the needs of patients and the healthcare system. The overall economic situation, reflected in this chart, influences the ability of patients and insurers to pay, as well as pricing pressure from pharmaceutical industry regulators.
Employees in the company, segment and market as a whole
Number of employees in the company Collegium Pharmaceutical
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on reducing the risk of abuse. This chart reflects the size of its commercial and research teams. The dynamics illustrate the company's efforts to promote its products to physicians and manage the drug lifecycle in a complex regulatory environment.
Share of the company's employees Collegium Pharmaceutical within the market segment - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-resistant products. This chart shows the company's share of the total number of specialists in this complex and socially significant field. It reflects its commitment to creating safer painkillers.
Number of employees in the market segment - Narco farm
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse-resistant products. This chart shows employment in the pharmaceutical sector related to narcotic analgesics. The growth in the number of specialists in this field reflects efforts to combat the opioid crisis by developing safer painkillers.
Number of employees in the market as a whole
Collegium Pharmaceutical focuses on the development and commercialization of pain medications, with an emphasis on reducing the risk of abuse. Their growth depends on the acceptance of their products by physicians and patients. This overall workload is not their driving force. The key driver is the need for safer analgesics amid the opioid crisis.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical specializes in pain medications. It is a commercial pharmaceutical company. Its value is derived from both its intellectual property and its sales and marketing team. This metric reflects the balance between the value of its patented products and the staff required to market them.
%20of%20the%20company%20Collegium%20Pharmaceutical%20(COLL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Collegium-Pharmaceutical-COLL&v=1772616000484 "Chart of market capitalization per employee (in thousands of dollars) of the company Collegium Pharmaceutical (COLL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Collegium Pharmaceutical (COLL) specializes in pain medications, using its technology (DETERx) to create abuse-resistant formulations (such as opioids). This indicator helps assess the market's perception of their niche pharmaceutical technology.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772616000567 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Collegium Pharmaceutical develops and markets pain medications, focusing on opioid abuse prevention technologies. It's a niche pharmaceutical company. This chart shows how the market evaluates its team's ability to create products with important social attributes that can provide them with a competitive advantage.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772616000600 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical specializes in pain medications, with a particular focus on abuse-deterrent technologies. This chart demonstrates how profitable their commercial strategy is in this complex and highly regulated niche, balancing R&D and sales costs with revenue from their proprietary drugs.
%20Chart%20Collegium%20Pharmaceutical%20(COLL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Collegium-Pharmaceutical-COLL&v=1772616000727 "Company Profit Per Employee (in thousands of dollars) Chart Collegium Pharmaceutical (COLL)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Collegium Pharmaceutical is a "specialty" pharma. They are "focused" on "treating" "pain" ("opioids" with "hack-proof" protection, "abuse-deterrent"). This chart shows the benchmark for "specialty pharma." In this "B2B R&D" sector, the benchmark is *high*. Profit per employee is "generated" by "patents" on a "niche," "high-margin" "product" "for" "doctors."
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772616000780 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Collegium Pharmaceutical specializes in pain medications, with a particular focus on abuse-deterrent technologies. This pharmaceutical company is at the intersection of a pressing social issue. This chart helps us understand how a niche pharmaceutical company focused on a single problem compares in terms of employee performance compared to the market.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772616000805 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical specializes in the development and commercialization of pain medications, with a focus on abuse prevention. Revenue per employee reflects the market success of its patented products. The graph shows how effectively the company's commercial team promotes its products to doctors and patients.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Collegium-Pharmaceutical-COLL&v=1772616000845 "Sales chart per company employee Collegium Pharmaceutical (COLL)")
Sales per employee in the market segment - Narco farm
Collegium Pharmaceutical specializes in pain medications, focusing on abuse-deterrent technologies. Their flagship product is Xtampza ER. This chart demonstrates how productive their commercial team is. It reflects their ability to persuade doctors to prescribe these more expensive but safer opioids.
Sales per employee for the market as a whole
Collegium Pharmaceutical (COLL) is a pharmaceutical company specializing in pain medications, particularly opioids with abuse-deterrent technology (Deterx). This chart shows performance in niche pharmaceuticals. After a product is launched (like Xtampza ER), commercialization becomes the primary goal. Growth in this metric reflects how successfully their sales team convinces doctors to prescribe their drug.
Short shares by company, segment and market as a whole
Shares shorted by company Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical specializes in pain medications, particularly opioids with abuse-deterrent technology. This chart shows bearish sentiment. Investors betting on the stock are looking at the overall decline in opioid prescriptions in the US due to regulatory pressure and litigation risks, which limits the company's long-term growth.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Collegium-Pharmaceutical-COLL&v=1772616000902 "Short Shares Chart for the Company Collegium Pharmaceutical (COLL)")
Shares shorted by market segment - Narco farm
Collegium Pharmaceutical (COLL) specializes in pain medications, particularly opioids with abuse-deterrent technology. This chart shows the betting against the opioid pharma sector. Investors short this segment because they fear lawsuits related to the opioid crisis or anticipate increased competition from generics.
Shares shorted by the overall market
Collegium Pharmaceutical specializes in chronic pain medications. This is certainly a non-discretionary demand. But the company operates in a complex, highly regulated environment. When this chart shows rising general fear, investors begin to avoid any complex stories and businesses with regulatory risks, which includes COLL.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical specializes in pain medications with abuse-resistant technology. The business carries regulatory risks. A chart above 70 may reflect strong sales or positive news. A level below 30 is often associated with concerns about generic competition or regulatory pressure.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Collegium-Pharmaceutical-COLL&v=1772616001044 "RSI 14 indicator chart for the company's stock Collegium Pharmaceutical (COLL)")
RSI 14 Market Segment - Narco farm
Collegium Pharmaceutical specializes in developing and marketing pain medications, using its DETERx technology to create abuse-deterrent products. This chart shows the overall sentiment in the painkiller pharmaceutical sector. It helps assess how investors view this niche amid the opioid crisis.
RSI 14 for the overall market
Collegium Pharmaceutical (COLL) produces abuse-resistant painkillers. This schedule is less important to the company than regulatory decisions. Demand for its products (opioid alternatives) is stable. In times of panic, investors may value the "defensive" demand in healthcare, although they are wary of competition.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast COLL (Collegium Pharmaceutical)
Collegium Pharmaceutical (COLL) is a pharmaceutical company specializing in pain management. Its flagship products are opioid analgesics (such as Xtampza ER) with DETERx abuse-deterrent technology. This chart shows the average analyst forecast. It reflects their estimate of painkiller prescription volumes amid the opioid crisis.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-COLL-Collegium-Pharmaceutical&v=1772616001350 "A chart showing analyst consensus forecasts for the expected stock price. COLL (Collegium Pharmaceutical)")
The difference between the consensus estimate and the actual stock price COLL (Collegium Pharmaceutical)
Collegium (COLL) is a pharmaceutical company focused on pain. Its core technology, DETERx, creates opioid medications (Xtampza ER) that are abuse-resistant. This chart shows the difference between the consensus estimate and the price, reflecting analysts' confidence in this niche.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-COLL-Collegium-Pharmaceutical&v=1772616001380 "A chart showing the difference between the consensus forecast and the actual stock price. COLL (Collegium Pharmaceutical)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Collegium Pharmaceutical is a specialty pharmaceutical company focused on pain management. It sells opioid medications with abuse-resistant mechanisms (Xtampza ER). This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe there will be sustainable demand for responsible pain relief.
Analysts' consensus forecast for the overall market share price
Collegium Pharmaceutical (COLL) is a niche pharmaceutical company focused on safe (difficult to crack) opioid painkillers. This chart of overall market sentiment is important. Demand for pain relief is protected. During a recession (pessimism), investors value the acyclical nature of COLL's business, which is unaffected by the state of the economy.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Collegium Pharmaceutical
Collegium Pharmaceutical is a pharmaceutical company focused on pain treatment. Their strategy is not new molecules, but rather the creation of abuse-deterrent versions of existing opioids. This chart evaluates their niche strategy and reflects their ability to maintain market share in this complex and highly regulated therapeutic area.
AKIMA Market Segment Index - Narco farm
Collegium Pharma (COLL) is a specialty pharmaceutical company focused on pain management; after Purdue's exit, the company became a leader in the production of opioid medications with abuse-resistant properties. This composite metric measures R&B. The graph shows the segment average. This benchmark: how does this niche (and risky) model (COLL) differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Collegium Pharmaceutical is a pharmaceutical company specializing in pain management. It's a leader in abuse-resistant opioids. This chart, which reflects the market average, provides a macro backdrop. It helps assess how Collegium, a strong cash flow generator in a challenging sector, compares to overall economic trends.
